National Biosafety Authority acting Chief Executive officer Mr. Nehemiah Ngetich explains a point to the Spouse of the Deputy President Dr. Joyce Kithure at Daystar University in Machakos County during a forum on STEM challenge for future innovation. Photo/Newsflash
By Newsflash Reporter
The National Biosafety Authority (NBA) has assured Kenyans that it remains committed to its mandate of overseeing the transfer, handling, and use of genetically modified organisms (GMOs) to safeguard human and animal health while ensuring environmental protection.
Speaking in Naivasha during a team-building exercise for board members and management, Acting Chief Executive Officer Nehemiah Ngetich emphasized the Authority’s critical role in ensuring biosafety compliance and maintaining the highest standards in service delivery.
“Through this exercise, I hope we will all gain valuable insights, build stronger bonds, and emerge more committed to our shared vision and goals,” said Mr Ngetich.
Read more: How sustainable agriculture is mitigating climate change in Kenya
He reiterated that Kenya has a robust regulatory framework that streamlines the process for companies and organizations seeking to import GMOs and their derived products. This framework outlines specific application requirements, safety assessments, and monitoring measures.
“This procedure aligns with Kenya’s commitment to food safety, environmental safeguards, and the economic welfare of its citizens,” he added.
NBA to remain independent
Agriculture Cabinet Secretary Mutahi Kagwe recently clarified that the Authority will not be merged with the Kenya Plant Health Inspectorate Service (KEPHIS) as previously proposed.
The CS explained that the two entities serve distinct roles and that their merger would conflict with Kenya’s international obligations.
The NBA’s mandate includes ensuring the safety of human and animal health while providing adequate environmental protection from potential risks associated with GMOs.
Kenya’s commitment to global biosafety standards
Kenya signed the Cartagena Protocol on Biosafety to the Convention on Biological Diversity (CBD) in 2000 and ratified it in 2003, designating the National Biosafety Authority (NBA) as the national focal point for its implementation.
The Cartagena Protocol is an international agreement designed to regulate GMOs, ensuring their safe use for humans, animals, and the environment. As part of the global Convention on Biological Diversity (CBD), the protocol provides a framework for utilizing biotechnology while acknowledging potential risks posed by emerging technologies.
The importance of teamwork
During the team-building exercise, NBA Board Chairperson Prof Jenesio Kinyamario highlighted the importance of collaboration in fulfilling the Authority’s mandate.
Read more: Macadamia farmers back govt policy amid price drop concerns
“Your unwavering commitment, hard work, and team spirit in executing your respective roles will ensure that we realize our mandate and succeed in whatever we do,” said Prof. Kinyamario.
With a strengthened team and renewed commitment, the NBA remains focused on enforcing biosafety regulations, promoting innovation in biotechnology while ensuring the safety and well-being of Kenyans.
